# CAL-MAINE FOODS INC (CALM) FY 2025 MD&A

Verbatim Item 7 Management's Discussion and Analysis from CAL-MAINE FOODS INC's 10-K for fiscal year 2025.

SEC filing source: https://www.sec.gov/Archives/edgar/data/16160/000156276225000170/calm2025053110K.htm
Accession: 0001562762-25-000170
Filing date: 2025-07-22
Report date: 2025-05-31
Extracted from a substantive MD&A body after the formal Item 7 span was a TOC or reference stub.
Confidence: high

Company profile: /company/CALM/
All MD&A years: /company/CALM/mda/
Previous year: /company/CALM/mda/fy2024/ (FY 2024)

RESULTS OF OPERATIONS

The following table sets
 
forth, for the fiscal
 
years indicated, certain items
 
from our Consolidated Statements
 
of Income expressed

as a percentage of net sales.

Fiscal Year Ended

May 31, 2025

June 1, 2024

Net sales

100.0

%

100.0

%

Cost of sales

56.6

%

76.7

%

Gross profit

43.4

%

23.3

%

Selling, general and administrative

7.4

%

10.9

%

Gain on involuntary conversions

—

%

(1.0)

%

Operating income

36.0

%

13.4

%

Total other income

1.6

%

2.0

%

Income before income taxes

37.6

%

15.4

%

Income tax expense

9.0

%

3.6

%

Net income

28.6

%

11.8

%

Less:
 
Net loss attributable to noncontrolling interest

—

%

(0.1)

%

Net income attributable to Cal-Maine Foods, Inc.

28.6

%

11.9

%

Fiscal Year
 
Ended May 31, 2025 Compared to Fiscal Year Ended June 1, 2024

NET SALES

Total net sales for fiscal 2025 were $4.3 billion compared to $2.3 billion for the prior fiscal year.

Shell egg sales represented
 
94.3% and 95.3% of
 
total net sales in
 
fiscal 2025 and 2024,
 
respectively. The
 
Company’s shell
 
egg

offerings, for both branded and
 
private-label products, include specialty
 
and conventional shell eggs.
 
Specialty shell eggs include

cage-free,
 
organic,
 
brown,
 
free-range,
 
pasture-raised
 
and
 
nutritionally
 
enhanced
 
shell
 
eggs.
 
Conventional
 
shell
 
eggs
 
sales

represent all
 
other shell
 
egg sales
 
not sold
 
as specialty
 
shell eggs.
 
The Company’s
 
egg products
 
and prepared
 
foods offerings

include liquid and
 
frozen egg products
 
and prepared foods
 
such as hard-cooked
 
eggs, egg wraps,
 
protein pancakes, crepes
 
and

wrap-ups. Other sales represent feed sales, miscellaneous byproducts and resale products.

The table below presents net sales in key categories (in thousands, except percentage data):

Fiscal Year Ended

May 31,

2025

June 1, 2024

% Change

Shell Eggs

$

4,019,910

$

2,217,408

81.3

%

Egg products and prepared foods

198,833

89,009

123.4

Other

43,142

20,026

115.4

Total net sales

$

4,261,885

$

2,326,443

83.2

%

31

The table below presents an analysis of our shell egg sales (in thousands, except percentage data):

May 31, 2025

June 1, 2024

Shell egg sales

Conventional

$

2,835,423

70.5

%

$

1,291,743

58.3

%

Specialty

1,184,487

29.5

%

925,665

41.7

%

Total shell egg sales

4,019,910

100.0

%

2,217,408

100.0

%

Dozens sold

Conventional

812,396

63.3

%

746,687

65.1

%

Specialty

470,215

36.7

%

400,946

34.9

%

Total dozens sold

1,282,611

100.0

%

1,147,633

100.0

%

Net average selling price per dozen

Conventional

$

3.490

$

1.730

Specialty

$

2.519

$

2.309

All shell eggs

$

3.134

$

1.932

Shell egg sales

-

For
 
fiscal
 
2025,
 
shell
 
egg
 
sales
 
increased
 
$1.8
 
billion
 
compared
 
to
 
fiscal
 
2024,
 
primarily
 
due
 
to
 
the
 
increase
 
in
 
net

average selling prices for conventional eggs, and to a lesser extent the increase in dozens sold.

-

For fiscal 2025, conventional egg sales increased $1.5 billion, or 119.5%, compared to fiscal 2024, primarily due to the

increase
 
in
 
conventional
 
egg
 
prices.
 
Changes in
 
price resulted
 
in
 
a $1.4
 
billion
 
increase in
 
net
 
sales and
 
changes
 
in

volume resulted
 
in a
 
$114
 
million increase
 
in net
 
sales. Conventional
 
egg prices
 
increased significantly
 
during fiscal

2025 due to a resurgence of HPAI outbreaks, which decreased the supply.

-

Specialty egg
 
sales increased
 
$258.8 million,
 
or 28.0%,
 
for fiscal
 
2025 compared
 
to fiscal
 
2024, primarily
 
due to a
 
17.3%

increase in
 
the volume
 
of specialty
 
dozens sold,
 
and to
 
a lesser
 
extent a
 
9.1% increase
 
in price.
 
Changes in
 
volume

resulted in a $159.9 million increase in net sales and changes in price resulted in a $98.7 million increase in net sales.

-

Our dozens sold
 
for fiscal 2025
 
increased 11.8%
 
compared to fiscal
 
2024. We
 
had an
 
increase in production
 
capacity

with the acquisition
 
of the commercial
 
shell egg production
 
and processing business
 
of ISE during
 
the first quarter
 
of

fiscal 2025 as well as the resumption of full operations at our facilities in Chase, KS, and Farwell, TX, which were shut

down in the third and fourth quarters of fiscal 2024 due to HPAI outbreaks.

Egg products and prepared foods sales

-

Egg products and prepared foods sales increased $109.8 million, or 123.4% compared to fiscal 2024, primarily due to a

138.7% increase in sales of liquid eggs, which had a $54.9
 
million positive impact on net sales, and a 41.4% increase in

volume of liquid egg products sold.
 
The increase in volume, which had a
 
$23.3 million positive impact on net
 
sales, is

primarily related to the acquisition of ISE, which included a breaking facility.

-

Our egg products net average selling price increased in fiscal 2025, compared to fiscal 2024 as the supply of shell eggs

used to produce egg products decreased due to the resurgence of HPAI outbreaks.

-

Sales from hard-cooked eggs increased
 
$22.7 million or 137.3% to 39.1
 
million in fiscal 2025, compared to
 
fiscal 2024,

as more processing capabilities came online throughout fiscal 2025 from our investments in MeadowCreek.

Other

-

Other sales increased compared to
 
the prior year period primarily
 
due to higher feed sales
 
related to our ISE acquisition.

32

COST OF SALES

Cost of
 
sales consists
 
of costs
 
directly related
 
to producing,
 
processing and
 
packing shell
 
eggs, purchases
 
of shell
 
eggs from

outside sources, processing and packing of egg products and other non-egg costs. Farm production costs are those costs
 
incurred

at the egg production facility, including feed, facility
 
(including labor), hen amortization and
 
other related farm production costs.

The following table presents the key variables affecting our cost of sales (in thousands, except cost per dozen data):

Fiscal Year Ended

May 31, 2025

June 1, 2024

% Change

Cost of Sales

Farm production

$

1,035,638

$

987,861

4.8

%

Processing, packaging, and warehouse

396,116

335,949

17.9

Egg purchases and other cost of sales

819,619

380,200

115.6

Egg products and prepared foods

159,627

80,862

97.4

Total cost of sales

$

2,411,000

$

1,784,872

35.1

%

Farm production costs (per dozen produced)

Feed

$

0.490

$

0.550

(10.9)

%

Other

$

0.428

$

0.433

(1.2)

%

Total farm production cost

$

0.918

$

0.983

(6.6)

%

Outside egg purchases (average cost per dozen)

$

3.67

$

2.16

69.9

%

Dozens produced

1,135,955

1,018,835

11.5

%

Percent produced to sold

88.6%

88.8%

(0.2)

%

Farm Production

-

Feed costs
 
per dozen
 
produced decreased
 
10.9% in
 
fiscal 2025
 
compared to
 
fiscal 2024,
 
primarily due
 
to lower
 
feed

ingredient prices. The decrease in feed cost per dozen
 
resulted in a decrease in cost of sales of
 
$68.2 million compared

to the prior year.

-

For fiscal 2025, the average daily CBOT market price was $4.38 per bushel for corn and $311 per ton of soybean meal,

representing decreases of 8.1% and 20.1%, respectively, as compared to the average daily CBOT prices for fiscal 2024.

-

Other farm production costs per dozen produced decreased primarily due to lower flock amortization. Feed costs

reached their peak in the second quarter of fiscal 2023 and have since trended downward. Lower costs resulted in

lower capitalized values of the flocks during the grow out phase, which reduced amortization cost over time.

Current indications for corn
 
and soybean project
 
a neutral stocks-to-use ratio
 
in the near term
 
compared with the levels
 
prevailing

today; however,
 
as long
 
as outside
 
factors remain
 
uncertain (including
 
weather patterns
 
and global
 
supply chain
 
disruptions),

volatility could remain.

Processing, packaging, and warehouse

-

Processing, packaging, and
 
warehouse costs increased
 
primarily due to
 
an 11.7%
 
increase in the
 
volume of processed

dozens as well as an increase in costs of packaging materials.

Egg purchases and other cost of sales

-

Costs in
 
this category
 
increased primarily due
 
to higher
 
shell egg
 
prices as
 
the average
 
cost per
 
dozen of
 
outside egg

purchases increased 69.9%
 
compared to fiscal
 
2024, as well
 
as due to an
 
increase of 27.6%
 
in dozens purchased.
 
Dozens

purchased increased due
 
to purchasing more
 
eggs to supply
 
our customers while
 
the nation experienced
 
lower supply

due to HPAI.

33

GROSS PROFIT

Gross
 
profit,
 
as
 
a
 
percentage
 
of
 
net
 
sales,
 
was
 
43.4%
 
for
 
fiscal
 
2025,
 
compared
 
to
 
23.3%
 
for
 
fiscal
 
2024.
 
The
 
increase
 
was

primarily due to higher net average selling
 
prices, particularly for conventional eggs, and higher volumes,
 
as well as lower feed

ingredient prices, partially offset by the increase in volume and price of outside egg purchases.

SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES

Selling, general, and administrative (“SGA”)
 
expenses include costs of delivery, marketing, and
 
other general and administrative

expenses. Delivery expense includes contract trucking expense
 
and all costs to maintain and operate
 
our fleet of trucks to deliver

products to
 
customers including
 
the related
 
payroll expenses.
 
Marketing expense
 
includes franchise
 
fees that
 
are submitted
 
to

Eggland’s Best, Inc. (“EB”) to
 
support the EB
 
brand, brokerage and
 
commission fees, and
 
other general marketing
 
expenses such

as
 
payroll expenses
 
for our
 
in-house sales
 
team. Other
 
general
 
and
 
administrative expenses
 
include corporate
 
payroll related

expenses
 
and
 
other
 
general
 
corporate
 
overhead
 
costs.
 
The
 
following
 
table
 
presents
 
an
 
analysis
 
of
 
our
 
SGA
 
expenses
 
(in

thousands):

Fiscal Year Ended

May 31, 2025

June 1, 2024

$ Change

% Change

Delivery expense

$

93,460

$

72,742

$

20,718

28.5

%

Marketing expense

53,861

52,285

1,576

3.0

%

Litigation loss contingency accrual

—

19,648

(19,648)

N.M.

%

Other general and administrative expenses

167,128

107,950

59,178

54.8

%

Total

$

314,449

$

252,625

$

61,824

24.5

%

N.M. - Not Meaningful

Delivery expense

-

The increased delivery expense is primarily due to an increase
 
in our sales volumes of egg and egg products
 
compared

to fiscal 2024.
 
Contract trucking
 
expenses increased
 
in connection
 
with our
 
acquisition of
 
ISE and our
 
facilities in
 
Chase,

KS and Farwell, TX being fully operational in fiscal year 2025.

Marketing expense

-

Marketing expense increased
 
slightly in fiscal
 
2025 compared to
 
fiscal 2024 primarily
 
due to an
 
increase in franchise

fees as specialty sales increased.

Litigation loss contingency accrual

-

In the second quarter of fiscal 2024, we accrued a $19.6 million loss contingency relating to a jury decision returned in

pending anti-trust
 
litigation. See
 
further discussion
 
in

Note 16 – Commitments and Contingencies

of Part
 
II. Item
 
8.

Notes to Consolidated Financial Statements.

Other general and administrative expenses

-

The increase
 
in other
 
general and
 
administrative expense
 
is primarily
 
due both
 
to an
 
increase in
 
the accrual
 
for anticipated

employee bonuses
 
and to
 
a $15
 
million increased
 
adjustment to
 
the fair
 
value of
 
contingent consideration
 
associated

with the
 
Fassio acquisition.
 
See further
 
discussion in

Note 4 – Fair Value Measurements

of Part
 
II. Item
 
8. Notes
 
to

Consolidated Financial Statements.

(GAIN) LOSS ON INVOLUNTARY
 
CONVERSIONS

For fiscal 2025
 
and 2024, we
 
recorded a loss
 
of $156 thousand
 
and gain of
 
$23.5 million, respectively. The gain
 
recorded in fiscal

2024 was due
 
to recoveries
 
under indemnity
 
and insurance
 
programs that exceeded
 
the amortized
 
book value
 
of the covered
 
assets

and our direct costs, primarily related to the HPAI outbreaks
 
at our Kansas and Texas facilities.

34

OPERATING
 
INCOME

As a result of the above, our operating income was $1.5 billion for fiscal 2025, compared to $312.5 million for fiscal 2024.

OTHER INCOME (EXPENSE)

Total
 
other
 
income
 
(expense)
 
consists
 
of
 
items
 
not
 
directly
 
charged
 
to,
 
or
 
related
 
to, operations
 
such
 
as
 
interest
 
income
 
and

expense, equity in
 
income or loss
 
of unconsolidated entities,
 
and patronage dividends, among
 
other items. Patronage dividends

are paid to us from our membership in the EB cooperative.

The Company recorded interest income of $48.7 million
 
in fiscal 2025, compared to $32.3 million in
 
fiscal 2024, primarily due

to significantly higher
 
cash and cash
 
equivalents and investment
 
securities available-for-sale balances
 
and yields. We
 
recorded

interest expense of $612
 
thousand and $549 thousand
 
in fiscal 2025 and
 
2024, respectively, primarily related to commitment
 
fees

on our Credit Facility described below.

INCOME TAXES

For the fiscal year ended
 
May 31, 2025, our pre-tax
 
income was $1.6 billion, compared
 
to $360.0 million for fiscal
 
2024. Income

tax expense
 
of $384.9
 
million was
 
recorded for
 
fiscal 2025
 
with an
 
effective tax
 
rate of
 
24.0%.
 
For fiscal
 
2024, income
 
tax

expense was $83.7 million with an effective tax rate of 23.2%.

Items causing
 
our effective
 
tax rate
 
to differ
 
from the
 
federal statutory
 
income tax
 
rate of
 
21% are
 
state income
 
taxes, certain

federal tax credits
 
and certain items included
 
in income or
 
loss for financial reporting
 
purposes that are
 
not included in taxable

income or loss
 
for income tax
 
purposes, including tax exempt
 
interest income, certain nondeductible
 
expenses, and net
 
income

or loss attributable to noncontrolling interest.

NET LOSS ATTRIBUTABLE
 
TO NONCONTROLLING INTEREST

Net loss attributable
 
to noncontrolling interest
 
was $1.8 million
 
for fiscal 2025
 
compared to a
 
$1.6 million net
 
loss for fiscal
 
2024.

NET INCOME ATTRIBUTABLE
 
TO CAL-MAINE FOODS, INC.

As a result
 
of the above,
 
net income attributable
 
to Cal-Maine Foods,
 
Inc. for fiscal
 
2025 was $1.2
 
billion, or $25.04
 
per basic

and $24.95 per diluted share, compared to $277.9 million, or $5.70 per basic and $5.69 per diluted share for fiscal 2024.

Fiscal Year
 
Ended June 1, 2024 Compared to Fiscal Year Ended June 3, 2023

The discussion of our results of operations for the fiscal year ended June 1, 2024 compared to the fiscal year ended June 3, 2023

can be found in Part II.
 
Item 7. Management's Discussion and Analysis of
 
Financial Condition and Results of Operations in
 
the

Company’s fiscal 2024 Annual Report on Form 10-K.

LIQUIDITY AND CAPITAL RESOURCES

We aim to maintain
 
a strong balance
 
sheet and liquidity, particularly
 
given the cyclical
 
nature of our
 
business. We believe a
 
strong

balance sheet supports our growth opportunities and stockholder returns. Our priorities for the use of cash in
 
recent periods have

included the payment of
 
dividends pursuant to our
 
variable dividend policy, inorganic growth through acquisitions
 
of businesses,

organic
 
growth
 
including
 
construction
 
and
 
conversion
 
of
 
cage-free
 
facilities
 
and
 
investment
 
in
 
value-added
 
products,
 
and

maintenance capital expenditures.

Working Capital and Current Ratio

Our working
 
capital at
 
May 31,
 
2025 was
 
$1.7 billion, compared
 
to $1.0
 
billion at
 
June 1,
 
2024. The
 
calculation of
 
working

capital is defined as
 
current assets less current
 
liabilities. Our current ratio was
 
6.4 at May 31,
 
2025 compared to 5.5
 
at June 1,

2024. The current ratio is calculated by dividing
 
current assets by current liabilities. The increase
 
in our current ratio is primarily

due to the increase in total current assets, which increased by $726.3 million to $2.0 billion at May 31, 2025, due to increases in

cash
 
and
 
cash
 
equivalents
 
and
 
investment
 
securities
 
available-for-sale.
 
Due
 
to
 
seasonal
 
factors
 
described
 
in

Part I. Item I.

Business – Seasonality

, we generally
 
expect our
 
need for working
 
capital to be
 
highest in
 
the fourth and
 
first fiscal
 
quarters ending

in May/June and August/September, respectively.

35

Cash Flows from Operating Activities

Net cash
 
provided by
 
operating activities
 
was $1.2
 
billion for
 
fiscal 2025,
 
compared to
 
$451.4 million for
 
fiscal 2024.
 
The increase

in
 
cash
 
flow
 
from
 
operating
 
activities
 
resulted
 
primarily
 
from
 
higher
 
net
 
average
 
selling
 
prices
 
per
 
dozen,
 
particularly
 
for

conventional eggs, increased volume of sales and
 
a decrease in feed ingredient costs compared
 
to the prior year,
 
partially offset

by the increase in volume and price of outside egg purchases.

Cash Flows from Investing Activities

For fiscal 2025, $575.5 million was
 
used in investing activities, primarily due
 
to purchases of investment securities,
 
purchases of

property, plant and equipment
 
and the acquisition
 
of assets of
 
ISE compared to
 
$412.6 million used
 
in investing activities
 
in fiscal

2024, primarily due to purchases
 
of investment securities, purchases of
 
property, plant and equipment and the Fassio acquisition.

Purchases of investment
 
securities were $1.2
 
billion in fiscal
 
2025 compared to
 
$573.6 million in
 
fiscal 2024. Sales
 
and maturities

of investment securities were
 
$907.6 million in fiscal
 
2025, compared to $358.9 million
 
for fiscal 2024. The increase
 
in sales and

maturities of investment securities is primarily due to the maturities of
 
short-term investments during fiscal 2025. Cash paid for

business acquisitions was $116.2 million in
 
fiscal 2025, primarily related to
 
the ISE acquisition, and
 
$53.7 million in fiscal 2024,

related to
 
the Fassio
 
acquisition. Purchases
 
of property,
 
plant and
 
equipment were
 
$161.3 million
 
and $147.1
 
million in
 
fiscal

2025 and 2024, respectively, primarily reflecting progress on our construction projects.

Cash Flows from Financing Activities

We
 
paid
 
dividends
 
totaling
 
$330.3
 
million
 
and
 
$91.9
 
million
 
in
 
fiscal
 
2025
 
and
 
2024,
 
respectively.
 
During
 
fiscal
 
2025,
 
we

repurchased $54.0 million
 
in shares of
 
Common Stock, primarily
 
under our share
 
repurchase program. See
 
“Share Repurchase

Program,” below.

Increase (decrease) in Cash and Cash Equivalents

As of May 31, 2025, cash increased $261.5 million since June 1, 2024, compared to a $54.9 million decrease
 
during fiscal 2024.

The increase is primarily due to the increase in net sales during fiscal 2025.

Acquisition of Echo Lake Foods

Subsequent to our fiscal 2025 year-end, we acquired Echo Lake Foods. The purchase price was approximately $258 million and

was funded with available cash on hand. For additional information, refer to Part II. Item 8. Notes to the Consolidated Financial

Statements,

Note 17 – Subsequent Events

.

Credit Facility

On November 15,
 
2021, we entered
 
into an Amended
 
and Restated Credit
 
Agreement (as amended,
 
the “Credit Agreement”)
 
with

a five-year term. The Credit Agreement provides
 
for a senior secured revolving credit facility
 
(the “Credit Facility”), in an initial

aggregate principal amount of up to $250 million. As of May 31, 2025, no amounts were borrowed under the Credit Facility. As

of May 31, 2025, we
 
had $4.7 million in outstanding
 
standby letters of credit, which
 
were issued under our Credit
 
Facility for the

benefit of
 
certain insurance
 
companies. On
 
March 25,
 
2025, we
 
entered into
 
the Second
 
Amendment to
 
the Credit
 
Facility to

amend the definition
 
of Change of
 
Control to exclude
 
the conversion of
 
all outstanding shares
 
of Class A
 
Common Stock into

Common Stock.
 
Refer to
 
Part II.
